KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung CancerKristen S. Hill, Jill Kolesar, Anthony McDowell et al.|Cancers|2021Cited by 23
Osimertinib (Osi) plus necitumumab (Neci) in EGFR-mutant NSCLC: An ETCTN California cancer consortium phase I study.Jonathan W. Riess, David R. Gandara, Susan Groshen et al.|Journal of Clinical Oncology|2019Cited by 18
Local data commons: the sleeping beauty in the community of data commonsJong Cheol Jeong, Eric B. Durbin, Joseph Hurt-Mueller et al.|BMC Bioinformatics|2022Cited by 1